MustGrow Biologics Corp. announced the approval of Health Canada's Pest Management Regulatory Agency ("PMRA") to commence large-scale field trials via NexusBioAg's 2024 BioAdvantage Trials Program ("BAT Program"). NexusBioAg, is a division of Univar Solutions, providing an expanded portfolio of crop nutrition solutions, including industry-leading inoculants, micronutrients, nitrogen stabilizers, and foliar products.

NexusBioAg is partnered with MustGrow to provide TerraMG to Canadian farmers, upon PMRA registraion, as a preplant soil treatment for diseases affecting canola and pulse crops. NexusBioAg's BAT Program is recognized as an industry leading field trialing program with an established process to gather data from large field scale trials across Canada. Since it's inception, NexusBioAg continues to expand the BAT Program footprint and engage with collaborators to evaluate products in the NexusBioAg pipeline.

Through the BAT Program, NexusBioAg validates product efficacy and establishes the product value and opportunity. The BAT Program will focus on MustGrow's TerraMG mustard-derived soil biopesticide technology for use in Canadian canola and pulse crop markets. The addition of this plant-based technology to the BAT Program further diversifies and expands NexusBioAg's extensive portfolio of inoculants, micronutrients, nitrogen stabilizers and foliars for the Canadian agricultural market.